| Atherosclerosis | Interaction | |||||
---|---|---|---|---|---|---|---|
(−) | (+) | ||||||
HTLV-1 infection | p | HTLV-1 infection | p | p | |||
(−) | (+) | (−) | (+) | ||||
Men | |||||||
 No. of subjects | 186 | 31 |  | 111 | 25 |  |  |
 No. of case (%) | 45 (24.2) | 7 (22.6) |  | 29 (26.1) | 12 (48.0) |  |  |
 Model 1 | 1.00 | 0.88 (0.35, 2.18) | 0.774 | 1.00 | 2.68 (1.09, 6.96) | 0.032 | 0.106 |
 Model 2 | 1.00 | 0.79 (0.30, 2.05) | 0.624 | 1.00 | 3.39 (1.24, 9.24) | 0.017 | 0.071 |
 Model 3 | 1.00 | 0.81 (0.31, 2.11) | 0.662 | 1.00 | 3.76 (1.34, 10.56) | 0.012 | 0.058 |
Women | |||||||
 No of subjects | 326 | 69 |  | 121 | 38 |  |  |
 No of case (%) | 63 (19.3) | 8 (11.6) |  | 23 (19.0) | 10 (26.3) |  |  |
 Model 1 | 1.00 | 0.51 (0.23, 1.14) | 0.100 | 1.00 | 1.56 (0.66, 3.70) | 0.309 | 0.083 |
 Model 2 | 1.00 | 0.51 (0.23, 1.16) | 0.108 | 1.00 | 1.46 (0.57, 3.69) | 0.430 | 0.111 |
 Model 3 | 1.00 | 0.50 (0.22, 1.15) | 0.102 | 1.00 | 1.48 (0.58, 3.76) | 0.413 | 0.090 |